ARCHIVES

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Awards $59M Contract For Key Project To consolidate Phase III Trial Administration

October 29, 1999

NCI-Approved Clinical Trials

December 31, 2004

AACR Journal Publishes a Henschke Letter Without Disclosure of Conflicts.

April 25, 2008

NIEHS Conference to Look At 21st Century Issues

April 1, 1988

713 Nurses Pass Certification exam At ONS Congress

July 8, 1988

Advisors Call for External Oversight, Coordination of NCI Clinical Trials.

February 25, 2005